TickerFacts.

Vsee Health, Inc. (VSEE): Cost of Revenue

Annual figures by period end, from SEC filings.

$7.26M
Year ended 2025-12-31
2023-12-31: $1.93M2024-12-31: $3.24M2025-12-31: $7.26M$7.26M
2023-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$7.26M+123.9%2026-03-31, From 2025-01-01
2024-12-31$3.24M+67.8%2026-03-31, From 2024-01-01
2023-12-31$1.93Mn/a2025-08-29, From 2023-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Services-Health Services), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Vsee Health, Inc. (VSEE)2025-12-31$7.26M+123.9%
EUDA Health Holdings Ltd (EUDA)2025-12-31$3.83M+17.8%
Longduoduo Co Ltd (LDDD)2026-06-30$17.0K-81.4%
Agape ATP Corp (ATPC)2025-12-31$686.0K+21.7%
Strata Critical Medical, Inc. (SRTA)2025-12-31$156.01M+33.1%
Omada Health, Inc. (OMDA)2025-12-31$89.27M+33.4%
GeneDx Holdings Corp. (WGS)2025-12-31$129.37M+16.5%

Compare VSEE, EUDA, LDDD, ATPC side by side · Screen every company in Services-Health Services ↗